[REGN] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 61.72%
YoY- -26.20%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 665,700 625,740 610,412 597,027 457,642 439,664 414,602 37.23%
PBT 203,119 175,263 198,153 225,684 147,692 141,831 134,559 31.68%
Tax 110,384 109,820 101,347 84,378 60,316 42,957 -335,848 -
NP 92,735 65,443 96,806 141,306 87,376 98,874 470,407 -66.22%
Tax Rate -54.34% -62.66% -51.15% -37.39% -40.84% -30.29% 249.59% -
Total Cost 572,965 560,297 513,606 455,721 370,266 340,790 -55,805 -
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 13.93 10.46 15.86 23.67 19.09 22.49 113.46 -75.39%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS 0.96 0.69 0.98 1.44 0.89 1.02 4.92 -66.45%
EPS Diluted 0.85 0.61 0.73 1.25 0.79 0.90 4.26 -65.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.